Clinical Trial

Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients .

Name: Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients . — clinical trial record (NCT06632522)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated October 9, 2024 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.

Summary

Clinical study of radiotherapy combined with Camrelizumab and Apatinib in the treatment of liver cancer patients with VP4.

Trial Details

NCT Number	NCT06632522
Lead Sponsor	Beijing Tsinghua Chang Gung Hospital
Conditions	Liver Cancer
Enrollment	46 participants
Start Date	2024-10-20
Primary Completion	2025-11-30 (estimated)
Study Completion	2026-12-30 (estimated)
Updated on ClinicalTrials.gov	2024-10-09